An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study.
We report posterior segment complications encountered with the use of the liquid perfluorocarbon, perfluoroperhydrophenanthrene (Vitreon) as an intraoperative adjunct to vitreoretinal surgery in 640 patients participating in the Vitreon Collaborative Study. We also evaluated postoperative complications in 60 patients in whom Viteron was intentionally left inside the vitreous cavity for periods ranging from 5 days to 4 weeks as a short-term retinal tamponade. The five most common postoperative complications among these patients as a whole were recurrent retinal detachment, with or without proliferative vitreoretinopathy (11.28%); macular pucker (5.85%); fibrinous reaction (4%); residual Vitreon (3.85%); and vitreous hemorrhage (2.57%).
Verma
L K
LK
LSU Eye Center, Louisiana State University Medical Center, School of Medicine, New Orleans 70112-2234, USA.
Peyman
G A
GA
Wafapoor
H
H
Greve
M D
MD
Millsap
C M
CM
Adile
S L
SL
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005128:Eye Diseases / Q000209:etiology / Q000601:surgery; D005260:Female; D005466:Fluorocarbons / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007223:Infant; D007431:Intraoperative Complications / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology; D012164:Retinal Diseases / Q000209:etiology* / Q000601:surgery; D014821:Vitrectomy / Q000009:adverse effects*; D014822:Vitreous Body / Q000473:pathology* / Q000601:surgery
D005466:Fluorocarbons; C047722:perfluorophenanthrene